Could a single IV dose and brain training offer new hope for depression?
NCT ID NCT06400121
Summary
This study is testing a new, fast-acting medication called apimostinel for treating major depression. Researchers want to see if it works better than a placebo and if adding a digital brain training program helps the benefits last longer. The trial will involve 150 adults with depression who will receive either the real medication or a placebo, and some will also complete the training.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Western Psychiatric Institute and Clinic
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.